Lallemand Inc. specializes in the development, production, and marketing of microorganisms and their derivatives, offering microbiological solutions for various industries including health, nutrition, and food.

Lallemand Inc.

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Corporation

Lallemand Inc. specializes in the development, production, and marketing of microorganisms and their derivatives.

Biotechnology Research

Lallemand Animal Nutrition

Food and Beverage Services

Lallemand Brewing

Biotechnology

Lallemand Health Solutions

Beverage Manufacturing

Lallemand Oenology

Food and Beverage Manufacturing

Lallemand Bio-Ingredients

Lallemand Plant Care

Lallemand Baking

Lallemand Biofuels & Distilled Spirits

Lallemand Specialty Cultures

Lallemand Food Probiotics

Pharmaceutical Manufacturing

Lallemand Pharma

Lallemand France

LALCAFÉ by Lallemand

Lallemand | 53,724 followers on LinkedIn. Lallemand is a privately owned company, founded at the end of the 19th century that researches, develops, produces and markets yeasts, bacteria and related products with the aim of reproducing, managing and optimizing natural fermentation processes in agri-food industries. Administrative offices for the parent company are in Montreal, Canada.

Today, Lallemand employs more than 4300 people working across more than 45 countries, on 5 continents.

Vice President Strategic Projects Bio-Ingredients at Lallemand

Per Henrik Larsen

R&D Innovation Leader

Asfia Qureshi

Mylène Caussette

Vice President Lallemand Plant Care / Producteur de thé en Occitanie / fondateur Acapella Torréfaction & Coffee Shop

Jean-Marc SANCHEZ

Lallemand

Metric
Company Name	Lallemand Inc.	Phibro Animal Health Corporation
Symbol		PAHC
MSH ID	COM:LALLEMAND	COM:PAHC
Market	PRIVATE	STOCKS
Sector	Consumer Goods	Healthcare
Industry	Biotechnology	Drug Manufacturers - Specialty & Generic
Country	CA	US
Stage
Employee Count		1.92K
Website	lallemand.com	pahc.com
LinkedIn	lallemand
Founders

Metric
Market Cap		663.85M
Enterprise Value
Monthly Web Traffic	34.51K
Web Traffic Growth	-0.50
Valuation
Raised Capital

Metric
Revenue		1.02B
Revenue (LTM)
Revenue (NTM)
Gross Profit		312.49M
EBITDA		98.60M
Operating Income		62.42M
Net Income		2.42M
EPS		0.06
Diluted EPS		0.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.31
Operating Profit Margin		0.06
EBITDA Margin		0.10
Net Profit Margin		0.02
Return on Equity		0.05
Return on Assets		0.02
Return on Capital Employed		0.07

COM:LALLEMAND

Lallemand Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		21.03
P/B Ratio		1.59
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.99
EV Multiple		7.27

Metric
Days Sales Outstanding		55.77
Days Payables Outstanding		41.49
Days Inventory Outstanding		153.11
Operating Cycle		209.10
Cash Conversion Cycle		163.40
Asset Turnover		1.04

Metric
Operating Cash Flow		87.59M
Free Cash Flow		46.36M
Cash Flow to Debt		0.23
Operating Cash Flow/Sales		0.09
Free Cash Flow Yield		0.01

Metric
Cash & Equivalents		70.61M
Accounts Receivable		-8.68M
Inventory		265.91M
Goodwill		54.56M
Debt to Capitalization		0.66
Debt to Assets		0.54
Current Ratio		3.39
Quick Ratio		1.67

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		-0.01
R&D to Revenue
SG&A to Revenue